Northern Trust’s 9 Meters Biopharma NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,461
| Closed | -$14.4K | – | 4595 |
|
|
2023
Q2 | $14.4K | Hold |
21,461
| – | – | ﹤0.01% | 4449 |
|
|
2023
Q1 | $29.8K | Sell |
21,461
-46
| -0.2% | -$87 | ﹤0.01% | 4374 |
|
|
2022
Q4 | $27.1K | Sell |
21,507
-497
| -2% | -$1.13K | ﹤0.01% | 4419 |
|
|
2022
Q3 | $94K | Sell |
22,004
-502
| -2% | -$2.49K | ﹤0.01% | 4132 |
|
|
2022
Q2 | $117K | Sell |
22,506
-80,372
| -78% | -$757K | ﹤0.01% | 4114 |
|
|
2022
Q1 | $1.23M | Sell |
102,878
-3,948
| -4% | -$53.9K | ﹤0.01% | 3329 |
|
|
2021
Q4 | $2.09M | Buy |
106,826
+2,168
| +2% | +$48.5K | ﹤0.01% | 3199 |
|
|
2021
Q3 | $2.72M | Buy |
104,658
+68,006
| +186% | +$1.6M | ﹤0.01% | 3116 |
|
|
2021
Q2 | $806K | Buy |
36,652
+20,615
| +129% | +$506K | ﹤0.01% | 3582 |
|
|
2021
Q1 | $375K | Buy |
16,037
+5,402
| +51% | +$166K | ﹤0.01% | 3911 |
|
|
2020
Q4 | $183K | Buy |
10,635
+4,571
| +75% | +$76.3K | ﹤0.01% | 3988 |
|
|
2020
Q3 | $99K | Buy |
6,064
+4,002
| +194% | +$48.5K | ﹤0.01% | 3969 |
|
|
2020
Q2 | $24K | Hold |
2,062
| – | – | ﹤0.01% | 4150 |
|
|
2020
Q1 | $21K | Hold |
2,062
| – | – | ﹤0.01% | 4086 |
|
|
2019
Q4 | $23K | Buy |
2,062
+686
| +50% | +$11.4K | ﹤0.01% | 4149 |
|
|
2019
Q3 | $29K | Sell |
1,376
-8,297
| -86% | -$168K | ﹤0.01% | 4126 |
|
|
2019
Q2 | $224K | Sell |
9,673
-1,308
| -12% | -$39.2K | ﹤0.01% | 3789 |
|
|
2019
Q1 | $424K | Buy |
10,981
+621
| +6% | +$26.9K | ﹤0.01% | 3581 |
|
|
2018
Q4 | $479K | Buy |
10,360
+11
| +0.1% | +$815 | ﹤0.01% | 3558 |
|
|
2018
Q3 | $1.41M | Buy |
10,349
+9,224
| +820% | +$1.58M | ﹤0.01% | 3366 |
|
|
2018
Q2 | $530K | Buy |
+1,125
| New | +$414K | ﹤0.01% | 3584 |
|
|
2017
Q4 | – | Sell |
-58
| Closed | -$8K | – | 4276 |
|
|
2017
Q3 | $8K | Hold |
58
| – | – | ﹤0.01% | 4210 |
|
|
2017
Q2 | $6K | Hold |
58
| – | – | ﹤0.01% | 4242 |
|
|
2017
Q1 | $14K | Buy |
+58
| New | +$17.4K | ﹤0.01% | 4182 |
|
Other funds holding NMTR
SM
SIS
RCM
BCMLT
SPIA
RFA
Northern Trust's NMTR Position: Q3 2023 in Review
Northern Trust sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 21,461 shares — an estimated $14.4K sold.
Northern Trust first reported a position in NMTR in Q1 2017 and held it in 24 quarters. The position peaked at $2.72M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.
- Northern Trust reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 21,461 9 Meters Biopharma shares in Q3 2023, an estimated $14.4K.
- Northern Trust first reported a position in 9 Meters Biopharma in Q1 2017 and held it in 24 quarters.
- Northern Trust's 9 Meters Biopharma position peaked at $2.72M in Q3 2021.
- 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.